Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Immunizations - Pneumoccocal Vaccination

Pneumococcal disease is a serious infection of the lungs, blood or outer lining of the brain. High death rates from pneumonia persist despite the existence of an effective vaccine against pneumococcus. (Note that not all pneumonia is caused by pneumococcus.). Relatively low rates of pneumococcal vaccination, particularly among the non-Hispanic Black population, are related to the high volume of deaths. Persons living in institutional settings are at particularly high risk.

Notes

Starting in 2011, BRFSS protocol requires that the NJBRFS incorporate a fixed quota of interviews from cell phone respondents along with a new weighting methodology called iterative proportional fitting or "raking". The new weighting methodology incorporates additional demographic information (such as education, race, and marital status) in the weighting process. These methodological changes were implemented to account for the underrepresentation of certain demographic groups in the land line sample (which resulted in part from the increasing number of U.S. households without land line phones). Comparisons between 2011 and prior years should therefore be made with caution. (More details about these changes can be found at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a3.htm.).   Asians: Data does not meet CDC minimum sample size criterion (i.e., N<50).

Data Source

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]

Definition

Percentage of adults age 65+ who reported ever receiving a pneumococcal vaccination in their lifetime.

Numerator

Number of survey respondents age 65+ who reported ever receiving a pneumococcal vaccine anytime during their life

Denominator

Number of survey respondents age 65+

Healthy People Objective: Increase the percentage of adults who are vaccinated against pneumococcal disease: Noninstitutionalized adults aged 65 years and older

U.S. Target: 90 percent
State Target: To be determined

Other Objectives

'''Healthy New Jersey 2020 Objective IMM-3''': Increase the percentage of non-institutionalized adults aged 65 years and older who have ever been vaccinated against pneumococcal infections.

How Are We Doing?

Lifetime pneumococcal vaccination rates for adults 65+ have significantly improved since 1999. The 1999 rate was 55%% (95% confidence interval, 50%-60%%) and by 2015 it had increased to 65% (61.6%-64.4%). However, due to a change in the BRFSS methodology in 2011, it is not possible to know if this is a significant change from 2010.

What Is Being Done?

Since 1998, NJDOH has adopted regulations requiring nursing homes to offer pneumococcal and influenza immunizations to all residents, and for hospitals to offer them to seniors who have been admitted for treatment. Education and outreach methods have also been made throughout the state.

Health Program Information

NJDOH Vaccine Preventable Disease Program: [http://www.state.nj.us/health/cd/]
Page Content Updated On 12/02/2016, Published on 09/25/2017
The information provided above is from the Department of Health's NJSHAD web site (https://nj.gov/health/shad). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Thu, 14 December 2017 13:39:14 from Department of Health, New Jersey State Health Assessment Data Web site: https://nj.gov/health/shad ".

Content updated: Wed, 15 Nov 2017 07:52:42 EST